CS
CLVS

Candriam SCA’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-533,832
Closed -$2.46M 946
2021
Q1
$2.46M Hold
533,832
0.02% 489
2020
Q4
$2.56M Sell
533,832
-851,803
-61% -$4.09M 0.02% 501
2020
Q3
$8.08M Buy
1,385,635
+87,185
+7% +$508K 0.08% 266
2020
Q2
$8.77M Buy
1,298,450
+298,535
+30% +$2.02M 0.09% 235
2020
Q1
$10.2M Buy
999,915
+62
+0% +$632 0.11% 209
2019
Q4
$10.4M Sell
999,853
-131,270
-12% -$1.37M 0.11% 211
2019
Q3
$4.45M Buy
1,131,123
+23,000
+2% +$90.4K 0.06% 342
2019
Q2
$16.4M Buy
1,108,123
+326,500
+42% +$4.83M 0.2% 112
2019
Q1
$19.4M Buy
781,623
+488,523
+167% +$12.1M 0.25% 90
2018
Q4
$5.26M Buy
293,100
+76,000
+35% +$1.36M 0.08% 272
2018
Q3
$6.38M Buy
217,100
+21,100
+11% +$620K 0.08% 273
2018
Q2
$8.91M Buy
196,000
+21,500
+12% +$978K 0.14% 188
2018
Q1
$9.21M Hold
174,500
0.16% 172
2017
Q4
$11.9M Sell
174,500
-43,000
-20% -$2.92M 0.21% 134
2017
Q3
$17.9M Buy
217,500
+48,500
+29% +$4M 0.31% 81
2017
Q2
$15.8M Buy
169,000
+49,000
+41% +$4.59M 0.3% 85
2017
Q1
$7.64M Sell
120,000
-11,000
-8% -$700K 0.15% 175
2016
Q4
$5.82M Sell
131,000
-18,000
-12% -$800K 0.13% 188
2016
Q3
$5.37M Buy
149,000
+102,000
+217% +$3.68M 0.13% 182
2016
Q2
$645K Buy
47,000
+15,000
+47% +$206K 0.02% 520
2016
Q1
$611K Sell
32,000
-4,300
-12% -$82.1K 0.02% 517
2015
Q4
$1.27M Sell
36,300
-6,500
-15% -$228K 0.03% 358
2015
Q3
$3.94M Sell
42,800
-17,200
-29% -$1.58M 0.1% 234
2015
Q2
$5.27M Sell
60,000
-10,000
-14% -$879K 0.11% 232
2015
Q1
$5.2M Sell
70,000
-39,000
-36% -$2.9M 0.1% 248
2014
Q4
$6.1M Buy
+109,000
New +$6.1M 0.13% 201